Asperpenoids A-C: three new lanostane triterpenoids with anti-inflammatory activities from Aspergillus ustus 3.3904
Yinhui Zhou1, Yutian Gan1, Jinling Chang1
1Huazhong University of Science and Technology, Tongji Medical College, School of Pharmacy, Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, Wuhan 430030, People's Republic of China.
None:
Three new lanostane triterpenoids, asperpenoids A-C (1-3), were isolated from the fungus Aspergillus ustus 3.3904. Their structures were elucidated through 1D/2D NMR and high-resolution mass spectrometry (HRMS) spectroscopic analysis, while the absolute configurations were confirmed via single-crystal X-ray diffraction (SC-XRD). Compounds 1-3 were evaluated for anti-inflammatory, cytotoxic, immunosuppressive, antibacterial, and α-glucosidase inhibitory activities. Notably, compounds 1 and 2 significantly inhibited nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages, with EC50 values of 14.05 and 7.49 μM, respectively. Compound 1 also dose-dependently inhibited interleukin-6 (IL-6) production in LPS-stimulated mouse splenocytes at a concentration range of 0.04-1.00 μM. Additionally, compound 1 exhibited moderate cytotoxic effects against HCT-116, A427, MCF-7, and HT-29, with IC50 values ranging from 18.23 to 39.00 μM. This study represents the first report of triterpenoids isolated from A. ustus.
Related Concept Videos
Antifungal Agents
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
